1887
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Gastrointestinal Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Buy this Microbiology Spectrum Article
Price Non-Member $15.00
  • Authors: Kevin Alby1, Irving Nachamkin2
  • Editors: Randall T. Hayden3, Donna M. Wolk4, Karen C. Carroll5, Yi-Wei Tang6
  • VIEW AFFILIATIONS HIDE AFFILIATIONS
    Affiliations: 1: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104; 2: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104; 3: Clinical and Molecular Microbiology, Department of Pathology, St. Jude’s Children’s Research Hospital, Memphis, TN; 4: Geisinger Clinic, Department of Laboratory Medicine, Danville, PA; 5: Johns Hopkins University Hospital, Baltimore, MD; 6: Clinical Microbiology Service, Memorial Sloane-Kettering Institute, New York, NY
  • Source: microbiolspec June 2016 vol. 4 no. 3 doi:10.1128/microbiolspec.DMIH2-0005-2015
  • Received 06 March 2015 Accepted 22 July 2015 Published 17 June 2016
  • Irving Nachamkin, nachamki@upenn.edu
image of Gastrointestinal Infections
    Preview this microbiology spectrum article:
    Zoom in
    Zoomout

    Gastrointestinal Infections, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/4/3/DMIH2-0005-2015-1.gif /docserver/preview/fulltext/microbiolspec/4/3/DMIH2-0005-2015-2.gif
  • Abstract:

    Gastrointestinal infections in the immunocompromised host are caused by the common bacterial, viral, fungal, and parasitic agents that also cause infections in the immunocompetent host. Of special consideration is that immunocompromised patients may be at increased risk for infection or disease severity and by pathogens not seen in the competent host. This chapter reviews the various agents, risk factors, and diagnostic approaches to detect gastrointestinal infections in this patient population.

  • Citation: Alby K, Nachamkin I. 2016. Gastrointestinal Infections. Microbiol Spectrum 4(3):DMIH2-0005-2015. doi:10.1128/microbiolspec.DMIH2-0005-2015.

Key Concept Ranking

Infectious Diseases
0.4067634
0.4067634

References

1. von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF. 2013. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 7:1354–1366. [PubMed][CrossRef]
2. Lai KK, Lamps LW. 2014. Enterocolitis in immunocompromised patients. Semin Diagn Pathol 31:176–191. [PubMed][CrossRef]
3. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. 2003. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 3:405–412. [PubMed][CrossRef]
4. Liu C, Crawford JM. 2005. The gastrointestinal tract, p 797–875. In Kumar V, Abbas AK, Fausto N (ed). Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier Saunders, Philadelphia, PA.
5. Overturf GD. 2006. Focal bacterial infections, p 347–384. In Remington JA, Klein JO, Wilson CB, Baker CJ (ed), Infectious Diseases of the Fetus and Newborn Infant, 6th ed. Elsevier Saunders, Philadelphia, PA. [CrossRef]
6. Aksoy DY, Tanriover MD, Uzun O, Zarakolu P, Ercis S, Ergüven S, Oto A, Kerimoglu U, Hayran M, Abbasoglu O. 2007. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol 18:183–189. [PubMed][CrossRef]
7. Ahdoot A, Kotler DP, Suh JS, Kutler C, Flamholz R. 2006. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol 40:385–390. [PubMed][CrossRef]
8. Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM. 2006. Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant 38:371–376. [PubMed][CrossRef]
9. Garrido RS, Aguado JM, Diaz-Pedroche C, Len O, Montejo M, Moreno A, Gurgui M, Torre-Cisneros J, Pareja F, Segovia J, Garcia M, Lumbreras C. 2006. A review of critical periods for opportunistic infection in the new transplantation era. Transplantation 82:1457–1462. [PubMed][CrossRef]
10. Marty FM, Rubin RH. 2006. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int 19:2–11. [PubMed][CrossRef]
11. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren M, Holmberg S, Jones JL. 2000. Epidemiology of human immunodeficiciency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30(Suppl 1):S5–S14. [PubMed][CrossRef]
12. Mönkemüller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM. 2005. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 50:230–234. [PubMed][CrossRef]
13. Danilenko DM, Wang H. 2012. The yin and yang of immunomodulatory biologics: assessing the delicate balance between benefit and risk. Toxicol Pathol 40:272–287. [PubMed][CrossRef]
14. Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, Shutt KA, Shapiro R, Thai N, Abu-Elmagd K, McCurry KR, Marcos A, Paterson DL. 2007. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 44:204–212. [PubMed][CrossRef]
15. Kohara MM, Blum RN. 2006. Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-alpha antibody. Clin Infect Dis 42:733–734. [PubMed][CrossRef]
16. Morelli J, Wilson FA. 2000. Does administration of infliximab increase susceptibility to listeriosis? Am J Gastroenterol 95:841–842. [PubMed][CrossRef]
17. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK; CDC; National Institutes of Health; Infectious Diseases Society of America. 2004. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 53(RR15):1–112. [PubMed]
18. Perlman DM, Ampel NM, Schifman RB, Cohn DL, Patton CM, Aguirre ML, Wang WL, Blaser MJ. 1988. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med 108:540–546. [PubMed][CrossRef]
19. Thompson SA, Blaser MJ. 2000. Pathogenesis of Campylobacter fetus infections, p 321–347. In Nachamkin I, Blaser MJ (ed), Campylobacter, 2nd ed. ASM Press, Washington, DC. [PubMed]
20. Vandenberg O, Dediste A, Houf K, Ibekwem S, Souayah H, Cadranel S, Douat N, Zissis G, Butzler JP, Vandamme P. 2004. Arcobacter species in humans. Emerg Infect Dis 10:1863–1867. [PubMed][CrossRef]
21. Rubin RH. 2002. Infection in the organ transplant recipient, p 573–679. In Rubin RH, Young LS (ed), Clinical Approach to Infection in the Compromised Host. Kluwer Academic/Plenum Publishers, New York, NY. [CrossRef]
22. Abreu C, Magro F, Vilas-Boas F, Lopes S, Macedo G, Sarmento A. 2013. Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature. J Crohns Colitis 7:175–182. [PubMed][CrossRef]
23. Clark NM, Chenoweth CE. 2003. Aeromonas infection of the hepatobiliary system: report of 15 cases and review of the literature. Clin Infect Dis 37:506–513. [PubMed][CrossRef]
24. Tsai MS, Kuo CY, Wang MC, Wu HC, Chien CC, Liu JW. 2006. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. J Microbiol Immunol Infect 39:150–154. [PubMed]
25. Rolston KV, Hopfer RL. 1984. Diarrhea due to Plesiomonas shigelloides in cancer patients. J Clin Microbiol 20:597–598. [PubMed]
26. Collini PJ, Bauer M, Kuijper E, Dockrell DH. 2012. Clostridium difficile infection in HIV-seropositive individuals and transplant recipients. J Infect 64:131–147. [PubMed][CrossRef]
27. McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. 2006. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 49:640–645. [PubMed][CrossRef]
28. Mofenson LM, Oleske J, Serchuck L, Van Dyke R, Wilfert C; CDC; National Institutes of Health; Infectious Diseases Society of America. 2004. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 53(RR14):1–92. [PubMed]
29. Sun HY, Chen MY, Wu MS, Hsieh SM, Fang CT, Hung CC, Chang SC. 2005. Endoscopic appearance of GI mycobacteriosis caused by the Mycobacterium avium complex in a patient with AIDS: case report and review. Gastrointest Endosc 61:775–779. [CrossRef]
30. Horvath KD, Whelan RL. 1998. Intestinal tuberculosis: return of an old disease. Am J Gastroenterol 93:692–696. [PubMed][CrossRef]
31. Jakubowski A, Elwood RK, Enarson DA. 1988. Clinical features of abdominal tuberculosis. J Infect Dis 158:687–692. [PubMed][CrossRef]
32. Hopewell PC, Jasmer RM. 2005. Overview of clinical tuberculosis, p 15–31. In Cole ST, Eisenach KD, McMurray DN, Jacobs WR Jr (ed), Tuberculosis and the Tubercle Bacillus. ASM Press, Washington, DC. [CrossRef]
33. Marshall JB. 1993. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 88:989–999. [PubMed]
34. Fox JG, Megraud F. 2007. Helicobacter, p 947–962. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed), Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC.
35. Fox JG. 2002. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50:273–283. [PubMed][CrossRef]
36. Guerrero AF, Straight TM, Eastone J, Spooner K. 2005. Gastric syphilis in an HIV-infected patient. AIDS Patient Care STDS 19:281–285. [PubMed][CrossRef]
37. Epstein JB, Hancock PJ, Nantel S. 2003. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:154–163. [CrossRef]
38. Mocroft A, Oancea C, van Lunzen J, Vanhems P, Banhegyi D, Chiesi A, Vinogradova E, Maayan S, Phillips AN, Lundgren J; EuroSIDA Study Group. 2005. Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. Am J Gastroenterol 100:1446–1454. [PubMed][CrossRef]
39. Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. 2002. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 40:3135–3139. [PubMed][CrossRef]
40. Sullivan DJ, Moran GP, Coleman DC. 2005. Candida dubliniensis: ten years on. FEMS Microbiol Lett 253:9–17. [PubMed][CrossRef]
41. Kahi CJ, Wheat LJ, Allen SD, Sarosi GA. 2005. Gastrointestinal histoplasmosis. Am J Gastroenterol 100:220–231. [PubMed][CrossRef]
42. Dave M, Purohit T, Razonable R, Loftus EV Jr. 2014. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis 20:196–212. [PubMed][CrossRef]
43. Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, Baddley JW, Vergidis P, Miller R, Andes D, Young JA, Hammoud K, Huprikar S, McKinsey D, Myint T, Garcia-Diaz J, Esguerra E, Kwak EJ, Morris M, Mullane KM, Prakash V, Burdette SD, Sandid M, Dickter J, Ostrander D, Antoun SA, Kaul DR. 2013. Histoplasmosis after solid organ transplant. Clin Infect Dis 57:1542–1549. [PubMed][CrossRef]
44. Assi M, McKinsey DS, Driks MR, O’Connor MC, Bonacini M, Graham B, Manian F. 2006. Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review. Diagn Microbiol Infect Dis 55:195–201. [PubMed][CrossRef]
45. Woods CW, McRill C, Plikaytis BD, Rosenstein NE, Mosley D, Boyd D, England B, Perkins BA, Ampel NM, Hajjeh RA. 2000. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 181:1428–1434. [PubMed][CrossRef]
46. Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. 1999. Endoscopic diagnosis of intestinal Penicilliosis marnefeei: report of three cases and review of the literature. Gastrointest Endosc 50:111–114. [CrossRef]
47. Samson RA, Yilmaz N, Houbraken J, Spierenburg H, Seifert KA, Peterson SW, Varga J, Frisvad JC. 2011. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud Mycol 70:159–183. [PubMed][CrossRef]
48. Bonacini M, Nussbaum J, Ahluwalia C. 1990. Gastrointestinal, hepatic, and pancreatic involvement with Cryptococcus neoformans in AIDS. J Clin Gastroenterol 12:295–297. [PubMed][CrossRef]
49. Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. 1988. Cryptococcosis of the colon resembling Crohn’s disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job’s) syndrome. Gastroenterology 94:808–812. [CrossRef]
50. Jacobs DH, Macher AM, Handler R, Bennett JE, Collen MJ, Gallin JI. 1984. Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job’s) syndrome. Gastroenterology 87:201–203. [PubMed]
51. Ng VL, Yajko DM, Hadley WK. 1997. Extrapulmonary pneumocystosis. Clin Microbiol Rev 10:401–418. [PubMed]
52. Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. 2002. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect 50:175–182. [PubMed][CrossRef]
53. Chionh F, Herbert KE, Seymour JF, Prince HM, Wolf M, Zimet A, Tam C, Kennedy GA. 2005. Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. Leuk Lymphoma 46:603–605. [PubMed][CrossRef]
54. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653. [PubMed][CrossRef]
55. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. 2006. Zygomycosis in solid organ tranplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 6:2365–2374. [PubMed][CrossRef]
56. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. 2005. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41:2268–2279. [PubMed][CrossRef]
57. Boeckh M, Marr KA. 2002. Infection in hematopoietic stem cell transplantation, p 527–571. In Rubin RH, Young LS (ed), Clinical Approach to Infection in the Compromised Host. Kluwer Academic/Plenum Publishers, New York, NY. [CrossRef]
58. Buller RS, Arens MQ, Storch GA. 2003. Cumitech 38. In Jamison RM (ed), Human Cytomegaloviruses. ASM Press, Washington, DC.
59. Patel R, Paya CV. 1997. Infections in solid-organ transplant recipients. Clin Microbiol Rev 10:86–124. [PubMed]
60. Kotton CN, Fishman JA. 2005. Viral infection in the renal transplant recipient. J Am Soc Nephrol 16:1758–1774. [PubMed][CrossRef]
61. Cosimi AB. 2002. Surgical aspects of infection in the compromised host, p 681–706. In Rubin RH, Young LS (ed), Clinical Approach to Infection in the Compromised Host, 4th ed. Kluwer Academic/Plenum Publishers, New York, NY. [CrossRef]
62. Delbridge MS, Karim MS, Shrestha BM, McKane W. 2006. Colitis in a renal transplant patient with human herpesvirus-6 infection. Transpl Infect Dis 8:226–228. [PubMed][CrossRef]
63. Hentrich M, Oruzio D, Jager G, Schlemmer M, Schleuning M, Schiel X, Hiddemann W, Kolb HJ. 2005. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 128:66–72. [PubMed][CrossRef]
64. Bok K, Green KY. 2012. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 367:2126–2132. [PubMed][CrossRef]
65. Green KY. 2014. Norovirus infection in immunocompromised hosts. Clin Microbiol Infect 20:717–723. [PubMed][CrossRef]
66. Roos-Weil D, Ambert-Balay K, Lanternier F, Mamzer-Bruneel MF, Nochy D, Pothier P, Avettand-Fenoel V, Anglicheau D, Snanoudj R, Bererhi L, Thervet E, Lecuit M, Legendre C, Lortholary O, Zuber J. 2011. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 92:61–69. [PubMed][CrossRef]
67. Bosch A, Pintó RM, Guix S. 2014. Human astroviruses. Clin Microbiol Rev 27:1048–1074. [PubMed][CrossRef]
68. Brown JR, Morfopoulou S, Hubb J, Emmett WA, Ip W, Shah D, Brooks T, Paine SM, Anderson G, Virasami A, Tong CY, Clark DA, Plagnol V, Jacques TS, Qasim W, Hubank M, Breuer J. 2015. Astrovirus VA1/HMO-C: An increasingly recognized neurotropic pathogen in immunocompromised patients. Clin Infect Dis 60:881–888. [PubMed][CrossRef]
69. Naccache SN, Peggs KS, Mattes FM, Phadke R, Garson JA, Grant P, Samayoa E, Federman S, Miller S, Lunn MP, Gant V, Chiu CY. 2015. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis 60:919–923. [PubMed][CrossRef]
70. Ison MG. 2006. Adenovirus infections in transplant recipients. Clin Infect Dis 43:331–339. [PubMed][CrossRef]
71. Walls T, Shankar AG, Shingadia D. 2003. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 3:79–86. [PubMed][CrossRef]
72. Rayani A, Bode U, Habas E, Fleischhack G, Engelhart S, Exner M, Schildgen O, Bierbaum G, Maria Eis-Hübinger A, Simon A. 2007. Rotavirus infections in paediatric oncology patients: a matched-pairs analysis. Scand J Gastroenterol 42:81–87. [PubMed][CrossRef]
73. Garcia LS. 2007. Parasitic infections in the compromised host, p 506–548. In Garcia LS (ed), Diagnostic Medical Parasitology 5th ed. ASM Press, Washington, DC. [CrossRef]
74. Vakil NB, Schwartz SM, Buggy BP, Brummitt CF, Kherellah M, Letzer DM, Gilson IH, Jones PG. 1996. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 334:19–23. [PubMed][CrossRef]
75. Didier ES, Weiss LM. 2011. Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis 24:490–495. [PubMed][CrossRef]
76. Christenson JC, Hill HR. 2002. Infections complicating congenital immunodeficiency syndromes, p 465–495. In Rubin RH, Young LS (ed). Clinical Approach to Infection in the Compromised Host 4th ed. Kluwer Academic/Plenum Publishers, New York, NY. [CrossRef]
77. Mondal D, Petri WA Jr, Sack RB, Kirkpatrick BD, Haque R. 2006. Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Trans R Soc Trop Med Hyg 100:1032–1038. [PubMed][CrossRef]
78. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. 2003. Amebiasis. N Engl J Med 348:1565–1573. [PubMed][CrossRef]
79. Roxby AC, Gottlieb GS, Limaye AP. 2009. Strongyloidiasis in transplant patients. Clin Infect Dis 49:1411–1423. [PubMed][CrossRef]
80. Keiser PB, Nutman TB. 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17:208–217. [CrossRef]
81. Rosenthal E, Marty P, del Giudice P, Pradier C, Ceppi C, Gastaut JA, Le Fichoux Y, Cassuto JP. 2000. HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leismania. Clin Infect Dis 31:1093–1095. [PubMed][CrossRef]
82. van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. 2014. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20:286–299. [PubMed][CrossRef]
83. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK; Infectious Diseases Society of America. 2001. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331–351. [PubMed][CrossRef]
84. Fitzgerald C, Nachamkin I. 2007. Campylobacter and Arcobacter, p 933–947. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed). Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC.
85. Gonzalez MD, Wilen CB, Burnham CA. 2015. Markers of intestinal inflammation for the diagnosis of infectious gastroenteritis. Clin Lab Med 35:333–344. [PubMed][CrossRef]
86. Valenstein P, Pfaller M, Yungbluth M. 1996. The use and abuse of routine stool microbiology: a College of American Pathologists Q-Probes study of 601 institutions. Arch Pathol Lab Med 120:206–211. [PubMed]
87. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, Carey R, Crandall C, Hurd S, Kaplan R, Neill M, Shea S, Somsel P, Tobin-D’Angelo M, Griffin PM, Gerner-Smidt P; Centers for Disease Control and Prevention (CDC). 2009. Recommendations for diagnosis of shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58(RR-12):1–14. [PubMed]
88. Johnson KE, Thorpe CM, Sears CL. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43:1587–1595. [PubMed][CrossRef]
89. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. 2013. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478–498, quiz 499. [PubMed][CrossRef]
90. Bartsch SM, Umscheid CA, Nachamkin I, Hamilton K, Lee BY. 2015. Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection. Clin Microbiol Infect 21:77.e1–9. [PubMed][CrossRef]
91. Franck KT, Nielsen RT, Holzknecht BJ, Ersboll AK, Fischer TK, Böttiger B. 2015. Norovirus genotypes in hospital settings: differences between nosocomial and community-acquired infections. J Infect Dis 212:881–888. [PubMed][CrossRef]
92. Bonifait L, Charlebois R, Vimont A, Turgeon N, Veillette M, Longtin Y, Jean J, Duchaine C. 2015. Detection and quantification of airborne norovirus during outbreaks in healthcare facilities. Clin Infect Dis 61:299–304. [PubMed][CrossRef]
93. Wessels E, Rusman LG, van Bussel MJ, Claas EC. 2014. Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG® GPP) testing in the diagnosis of infectious gastroenteritis. Clin Microbiol Infect 20:182–187. [PubMed][CrossRef]
94. Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, Rogatcheva M, Kanack KJ, Bourzac KM. 2015. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol 53:915–925. [PubMed][CrossRef]
95. Ribes JA, Vanover-Sams CL, Baker DJ. 2000. Zygomycetes in human disease. Clin Microbiol Rev 13:236–301. [PubMed][CrossRef]
96. Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, Jacobi V, Just-Nübling G, Bialek R. 2007. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 44:1078–1083. [PubMed][CrossRef]
97. Hope WW, Walsh TJ, Denning DW. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5:609–622. [PubMed][CrossRef]
98. Koskenvuo M, Lautenschlager I, Kardas P, Auvinen E, Mannonen L, Huttunen P, Taskinen M, Vettenranta K, Hirsch HH. 2015. Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient. J Clin Virol 62:72–74. [PubMed][CrossRef]
99. Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O’Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P. 2014. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:1329–1334. [PubMed][CrossRef]
100. Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. 2015. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17:33–38. [PubMed][CrossRef]
101. Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D, Pötschger U, Lawitschka A, Peters C, Fritsch G, Matthes-Martin S. 2010. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 24:706–714. [PubMed][CrossRef]
102. Jeulin H, Salmon A, Bordigoni P, Venard V. 2011. Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients. Clin Microbiol Infect 17:1674–1680. [PubMed][CrossRef]
103. Cotte L, Drouet E, Bissuel F, Denoyel GA, Trepo C. 1993. Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol 31:2066–2069. [PubMed]
104. Mills AM, Guo FP, Copland AP, Pai RK, Pinsky BA. 2013. A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissue. Am J Surg Pathol 37:995–1000. [PubMed][CrossRef]
105. Wilcox CM, Rodgers W, Lazenby A. 2004. Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol 2:564–567. [PubMed][CrossRef]
106. Wilcox CM, Straub RF, Schwartz DA. 1996. Prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointest Endosc 44:587–593. [PubMed][CrossRef]
107. Griffiths PD. 2002. Herpes group virus infection in the compromised host, p 361–403. In Rubin RH, Young LS (ed). Clinical Approach to Infection in the Compromised Host, 4th ed. Kluwer Academic/Plenum Publishers, New York, NY. [CrossRef]
108. Styczynski J, Reusser P, Einsele H, de la Camara R, Cordonnier C, Ward KN, Ljungman P, Engelhard D; Second European Conference on Infections in Leukemia. 2009. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 43:757–770. [PubMed][CrossRef]
109. Durand CM, Marr KA, Arnold CA, Tang L, Durand DJ, Avery RK, Valsamakis A, Neofytos D. 2013. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis 57:1550–1559. [PubMed][CrossRef]
110. Pickering LK, Matson DO, Mitchell DK, O’Ryan ML. 2000. Rotavirus, enteric adenoviruses, Norwalk virus, and other gastroenteritis tract viruses, p 270–94. In Specter S, Hodinka RL, Young SA (ed), Clinical Virology Manual, 3rd ed. ASM Press, Washington, DC.
111. Robinson C, Echavarria M. 2007. Adenoviruses, p 1589–1600. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed), Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC.
112. Logan C, O’Leary JJ, O’Sullivan N. 2006. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. J Clin Microbiol 44:3189–3195. [PubMed][CrossRef]
113. de Bruin E, Duizer E, Vennema H, Koopmans MP. 2006. Diagnosis of norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 137:259–264. [PubMed][CrossRef]
114. Wilhelmi de Cal I, Revilla A, del Alamo JM, Román E, Moreno S, Sánchez-Fauquier A. 2006. Evaluation of two commercial enzyme immunoassays for the detection of norovirus in faecal samples from hospitalized children with spordic acute gastroenteritis. Clin Microbiol Infect 13:341–343. [PubMed][CrossRef]
115. Rodriguez-Baez N, O’Brien R, Qiu SQ, Bass DM. 2002. Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr 35:64–68. [PubMed][CrossRef]
116. Traoré O, Belliot G, Mollat C, Piloquet H, Chamoux C, Laveran H, Monroe SS, Billaudel S. 2000. RT-PCR identification and typing of astroviruses and Norwalk-like viruses in hospitalized patients with gastroenteritis: evidence of nosocomial infections. J Clin Virol 17:151–158. [PubMed][CrossRef]
117. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK; Infectious Diseases Society of America. 2001. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331–351. [PubMed][CrossRef]
118. Garcia LS. 2007. Histologic identification of parasites, p 616–669. In Garcia LS (ed), Diagnostic Medical Parasitology, 5th ed. ASM Press, Washington, DC. [CrossRef]
119. Garcia LS. 2007. Antibody and antigen detection in parasitic infections, p 592–615. In Garcia LS (ed), Diagnostic Medical Parasitology, 5th ed. ASM Press, Washington, DC. [CrossRef]
microbiolspec.DMIH2-0005-2015.citations
cm/4/3
content/journal/microbiolspec/10.1128/microbiolspec.DMIH2-0005-2015
Loading

Citations loading...

Loading

Article metrics loading...

/content/journal/microbiolspec/10.1128/microbiolspec.DMIH2-0005-2015
2016-06-17
2017-08-24

Abstract:

Gastrointestinal infections in the immunocompromised host are caused by the common bacterial, viral, fungal, and parasitic agents that also cause infections in the immunocompetent host. Of special consideration is that immunocompromised patients may be at increased risk for infection or disease severity and by pathogens not seen in the competent host. This chapter reviews the various agents, risk factors, and diagnostic approaches to detect gastrointestinal infections in this patient population.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Microbial agents causing upper- and lower-gastrointestinal infections in the compromised host.

Source: microbiolspec June 2016 vol. 4 no. 3 doi:10.1128/microbiolspec.DMIH2-0005-2015
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Algorithm for diagnostic approach to lower-gastrointestinal infections in the compromised host.

Source: microbiolspec June 2016 vol. 4 no. 3 doi:10.1128/microbiolspec.DMIH2-0005-2015
Permissions and Reprints Request Permissions
Download as Powerpoint

Tables

Generic image for table
TABLE 1

Microbial agents causing more severe or complicated gastrointestinal infection in the immunocompromised host

Source: microbiolspec June 2016 vol. 4 no. 3 doi:10.1128/microbiolspec.DMIH2-0005-2015

Supplemental Material

No supplementary material available for this content.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error